Investigational therapies for the treatment of atherosclerosis.

about

Microsomal transfer protein inhibitors, new approach for treatment of familial hypercholesterolemia, review of the literature, original findings, and clinical significance.Transporters for the Intestinal Absorption of Cholesterol, Vitamin E, and Vitamin K.

P2860

Q38325807-141DBB73-2F9D-48A7-8548-ADBBA93F2071 Q38768787-B6FD2DBD-16E7-4CD3-B905-F92B9B36454A

P2860

Investigational therapies for the treatment of atherosclerosis.

Item

http://www.wikidata.org/entity/Q38214386

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Investigational therapies for the treatment of atherosclerosis.

@en

type

Item

label

Investigational therapies for the treatment of atherosclerosis.

@en

prefLabel

Investigational therapies for the treatment of atherosclerosis.

@en

P1476

Investigational therapies for the treatment of atherosclerosis.

@en

P2093

Daphne Owens

http://www.w3.org/2001/XMLSchema#string

Gerald H Tomkin

http://www.w3.org/2001/XMLSchema#string

P2860

RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist

Multiple functions of microsomal triglyceride transfer protein

The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation

miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling

PCSK9 LNA antisense oligonucleotides induce sustained reduction of LDL cholesterol in nonhuman primates

JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs.

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia

Effect of torcetrapib on the progression of coronary atherosclerosis

The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions

P304

1411-1421

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2014.922950

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24857672

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

Investigational therapies for the treatment of atherosclerosis.

about

P2860

P2860

Investigational therapies for the treatment of atherosclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921